CCL15 and neoplasm: According to our knowledge, the current study is the first that links the diagnostic characteristics of CCL2, CCL4, and CCL15 with the well-established, classical tumor markers (CEA and CA 19-9) and CRP—which is the marker of inflammation—in CRC patients, and not only in the entire study group, but also in subjects divided according to TNM stage.